Abstract: A method of inhibiting one or more psychiatric disorders is disclosed comprising administering a compound of formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, C.sub.1-6, alkyl, C.sub.1-6 alkoxy or (tertiary amino)C.sub.1-6 alkoxy; and R.sup.2 and R.sup.3 are individually hydrogen or C.sub.1-6 alkyl, or a pharmaceutically acceptable salt thereof.
Type:
Grant
Filed:
February 20, 1997
Date of Patent:
May 26, 1998
Assignee:
Novo Nordis A/S
Inventors:
Birte Kloppenborg Skrumsager, Erik Bardrum Nielsen, Birgitte Hjort Guldhammer